4.8 Article

Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation

期刊

CELL REPORTS
卷 32, 期 12, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2020.108176

关键词

-

资金

  1. Novo Nordisk Foundation Center for Protein Research
  2. Novo Nordisk Foundation [NNF14CC0001, NNF13OC0006477]
  3. Danish Council of Independent Research [4002-00051, 4183-00322A, 8020-00220B, 0135-00096B]
  4. Danish Cancer Society [R146-A9159-16-S2]
  5. Novo Nordisk Foundation, Copenhagen Bioscience PhD Programme [NNF19SA0035442]
  6. National Institutes of Health-supported National Center for Quantitative Biology of Complex Systems [P41GM108538]
  7. European Union [EPIC-XS-823839]

向作者/读者索取更多资源

ADP-ribosylation (ADPr) is a post-translational modification that plays pivotal roles in a wide range of cellular processes. Mass spectrometry (MS)-based analysis of ADPr under physiological conditions, without relying on genetic or chemical perturbation, has been hindered by technical limitations. Here, we describe the applicability of activated ion electron transfer dissociation (AI-ETD) for MS-based proteomics analysis of physiological ADPr using our unbiased Af1521 enrichment strategy. To benchmark AI-ETD, we profile 9,000 ADPr peptides mapping to >5,000 unique ADPr sites from a limited number of cells exposed to oxidative stress and identify 120% and 28% more ADPr peptides compared to contemporary strategies using ETD and electron-transfer higher-energy collisional dissociation (EThcD), respectively. Under physiological conditions, AI-ETD identifies 450 ADPr sites on low-abundant proteins, including in vivo cysteine modifications on poly(ADP-ribosyl)polymerase (PARP) 8 and tyrosine modifications on PARP14, hinting at specialist enzymatic functions for these enzymes. Collectively, our data provide insights into the physiological regulation of ADPr.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据